{
  "title": "GLP Chart change-log",
  "description": "Weekly verified changes to US GLP-1 telehealth programs: price moves, lock-in changes, market exits, corrections.",
  "home_page_url": "https://glpchart.com/newsroom/",
  "feed_url": "https://glpchart.com/newsroom/changes.json",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "week_of": "2026-05-25",
  "tldr": "All 25 programs re-verified Monday. Quiet week overall. Three drift fixes in the PM spot-check: Found restructured to all-inclusive pricing ($199/mo cash-pay, meds bundled), NovoCare Wegovy pill launched at $149/mo (beating the injection intro), and LillyDirect Zepbound note corrected for 5mg tier ($399/mo, not $449). Plus Hims intro trim ($49→$39) and Knownwell URL fix from the AM run.",
  "changes": [
    {
      "type": "price",
      "provider_slug": "hims",
      "provider_name": "Hims & Hers",
      "old_value": "$49/mo intro",
      "new_value": "$39/mo intro",
      "summary": "First-month membership intro trimmed $49 to $39. Ongoing membership $149/mo unchanged. Cloudflare-blocked checkout; verified via NovoNordisk-partnership press and Hims's own drug-pricing page.",
      "direction": "good",
      "drift_amount": -10
    },
    {
      "type": "correction",
      "provider_slug": "knownwell",
      "provider_name": "Knownwell",
      "old_value": "site_url: knownwell.com",
      "new_value": "site_url: knownwell.co",
      "summary": "The .com domain now hosts an unrelated B2B SaaS product. The healthcare practice migrated to knownwell.co. URL fixed; pricing model unchanged (insurance-primary, $299 first visit / $149 follow-up self-pay).",
      "direction": "editorial"
    },
    {
      "type": "policy",
      "provider_slug": "embla",
      "provider_name": "Embla",
      "summary": "Re-confirmed B2B-only this week: $399 PEPM employer pricing; no individual intake path on joinembla.com. The 'Join as an individual' link loops back to the homepage. Editorial review queued under Pledge #7.",
      "direction": "neutral"
    },
    {
      "type": "structure",
      "provider_slug": "found",
      "provider_name": "Found",
      "old_value": "$129/mo membership + ~$189/mo sema separately (~$318/mo all-in cash)",
      "new_value": "$199/mo cash-pay all-in (12-mo plan), $299/mo monthly all-in; $149/mo insurance (12-mo plan)",
      "summary": "Found switched from separate-billing (membership + medication billed apart) to all-inclusive plans. Cash-pay 12-month plan is now $199/mo including compounded semaglutide. Lock-in structure moved from 6-month to 12-month for the lower price. starts_includes_med updated to true.",
      "direction": "good",
      "drift_amount": -119
    },
    {
      "type": "price",
      "provider_slug": "novocare-wegovy",
      "provider_name": "NovoCare Wegovy (manufacturer)",
      "old_value": "$349/mo injection (intro $199 through June 2026)",
      "new_value": "$149/mo Wegovy pill (1.5mg or 4mg self-pay); injection unchanged at $199 intro / $349 standard",
      "summary": "NovoCare launched Wegovy oral pill at $149/mo self-pay for the 1.5mg and 4mg doses. Injection intro ($199) still active through June 30. Cheapest self-pay Wegovy is now $149/mo via pill. MEDICATIONS array in page.tsx updated. NovoCare href corrected (old /wegovy/ path 404s; now /patient/medicines/wegovy.html).",
      "direction": "good",
      "drift_amount": -200
    },
    {
      "type": "correction",
      "provider_slug": "lillydirect-zepbound",
      "provider_name": "LillyDirect Zepbound (manufacturer)",
      "old_value": "note: '2.5mg starting dose; $449/mo at maintenance doses'",
      "new_value": "note: '2.5mg starting dose; $399/mo at 5mg; $449/mo at 7.5mg+ maintenance'",
      "summary": "Zepbound 5mg dose is $399/mo, not $449. Note in MEDICATIONS array corrected to reflect the three-tier pricing: $299 (2.5mg), $399 (5mg), $449 (7.5mg+).",
      "direction": "editorial"
    }
  ]
}